A recent report regarding the global Regenerative Medicine market estimates it’s value will reach US$24.7 billion by 2017.? This report demonstrates the massive investment potential in this field and once again validates the direction Grace Century has been taking with regard to supporting innovative Regenerative Medicine projects.
?Investors would do well to take notice of larger trends within Industries, such as the projected growth in the Regenerative medicine sector. At Grace Century, we are cognizant of having to find the right player withing a broad sector, however there is a lot to be said for a rising tide that raises all boats? says Scott Wolf, Grace Century?s CEO and Director of Research.
